PL2694971T3 - Testy receptora steroidowego do wykrywania komórek nowotworowych - Google Patents
Testy receptora steroidowego do wykrywania komórek nowotworowychInfo
- Publication number
- PL2694971T3 PL2694971T3 PL12716825T PL12716825T PL2694971T3 PL 2694971 T3 PL2694971 T3 PL 2694971T3 PL 12716825 T PL12716825 T PL 12716825T PL 12716825 T PL12716825 T PL 12716825T PL 2694971 T3 PL2694971 T3 PL 2694971T3
- Authority
- PL
- Poland
- Prior art keywords
- tumor cells
- steroid receptor
- receptor assays
- detecting tumor
- detecting
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/54—Determining the risk of relapse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161470618P | 2011-04-01 | 2011-04-01 | |
US13/432,248 US20120252038A1 (en) | 2011-04-01 | 2012-03-28 | Steroid receptor assays |
PCT/US2012/031338 WO2012135560A1 (en) | 2011-04-01 | 2012-03-30 | Steroid receptor assays for detecting tumor cells |
EP12716825.0A EP2694971B1 (en) | 2011-04-01 | 2012-03-30 | Steroid receptor assays for detecting tumor cells |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2694971T3 true PL2694971T3 (pl) | 2020-11-02 |
Family
ID=46927724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL12716825T PL2694971T3 (pl) | 2011-04-01 | 2012-03-30 | Testy receptora steroidowego do wykrywania komórek nowotworowych |
Country Status (20)
Country | Link |
---|---|
US (1) | US20120252038A1 (pl) |
EP (1) | EP2694971B1 (pl) |
JP (2) | JP2014513283A (pl) |
KR (1) | KR20140019823A (pl) |
CN (1) | CN103608681A (pl) |
BR (1) | BR112013025287A2 (pl) |
CA (1) | CA2831567A1 (pl) |
CY (1) | CY1123191T1 (pl) |
DK (1) | DK2694971T3 (pl) |
ES (1) | ES2793485T3 (pl) |
HR (1) | HRP20200860T1 (pl) |
HU (1) | HUE050711T2 (pl) |
IL (1) | IL228564B (pl) |
LT (1) | LT2694971T (pl) |
MX (1) | MX360225B (pl) |
PL (1) | PL2694971T3 (pl) |
PT (1) | PT2694971T (pl) |
RS (1) | RS60678B1 (pl) |
SI (1) | SI2694971T1 (pl) |
WO (1) | WO2012135560A1 (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10253107B2 (en) * | 2012-10-26 | 2019-04-09 | The University Of Queensland | Use of endocytosis inhibitors and antibodies for cancer therapy |
CN109975097A (zh) * | 2019-04-18 | 2019-07-05 | 山东师范大学 | 一种基于适配体的肿瘤细胞染色探针组合 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292638A (en) * | 1990-12-07 | 1994-03-08 | The Regents Of The University Of California | Method of determining functional estrogen receptors for prognosis of cancer |
CA2077781A1 (en) * | 1991-09-23 | 1993-03-24 | James W. Bacus | Method and apparatus for automated assay of biological specimens |
AU3374597A (en) | 1996-06-07 | 1998-01-05 | Immunivest Corporation | Magnetic separation employing external and internal gradients |
WO1999041613A1 (en) * | 1998-02-12 | 1999-08-19 | Immunivest | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
BR0207290A (pt) * | 2001-02-16 | 2005-06-07 | Immunivest Corp | Método para analisar um paciente quanto à presença de uma malignidade, célula maligna isolada das células cultivadas, vacina de tumor, molécula associada com diátese de tumor alterada, métodos para determinar alterações em moléculas associadas com diátese de tumor como um meio para predizer a eficácia da terapia, como um meio para analisar dosagem apropriada para terapia, como um meio para monitorar eficácia da terapia, como um meio para analisar progressão de câncer, para realizar uma biópsia de corpo inteiro em um paciente, e para identificar alterações em uma célula de tumor circulante relativamente a células presentes numa massa de tumor in situ, e, kit de teste para analisar uma amostra de paciente quanto à presença de uma célula maligna não-hematopoiética |
JP2005501236A (ja) * | 2001-08-23 | 2005-01-13 | イムニベスト・コーポレイション | 分析用の細胞および生物学的検体の安定化 |
IL161357A0 (en) * | 2001-10-26 | 2004-09-27 | Immunivest Corp | Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
CN1871517A (zh) * | 2002-02-19 | 2006-11-29 | 免疫公司 | 快速有效分离循环癌细胞的方法和试剂 |
US7011794B2 (en) | 2002-11-25 | 2006-03-14 | Immunivest Corporation | Upon a cartridge for containing a specimen sample for optical analysis |
WO2004076643A2 (en) * | 2003-02-27 | 2004-09-10 | Immunivest Corporation | CIRCULATING TUMOR CELLS (CTC’s): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS |
US20040171091A1 (en) * | 2003-02-27 | 2004-09-02 | Cell Work, Inc. | Standardized evaluation of therapeutic efficacy based on cellular biomarkers |
US20090291920A1 (en) * | 2006-04-18 | 2009-11-26 | Wellstat Biologics Corporation | Detection of steroid receptors on circulating carcinoma cells and treatment |
JP5350369B2 (ja) * | 2007-05-31 | 2013-11-27 | ダコ デンマーク アクティーゼルスカブ | 乳癌治療および予後におけるesrコピー数変化の利用方法 |
US20090061456A1 (en) * | 2007-08-30 | 2009-03-05 | Allard William J | Method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells |
US8071395B2 (en) * | 2007-12-12 | 2011-12-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and apparatus for magnetic separation of cells |
JP2010151678A (ja) * | 2008-12-25 | 2010-07-08 | Olympus Corp | 大腸癌の診断方法および大腸癌診断用キット |
WO2011002649A1 (en) * | 2009-06-30 | 2011-01-06 | Veridex, Llc | Analysis of circulating tumor-related microparticles |
EP3306321A1 (en) * | 2010-07-07 | 2018-04-11 | The Regents of The University of Michigan | Diagnosis and treatment of breast cancer |
-
2012
- 2012-03-28 US US13/432,248 patent/US20120252038A1/en not_active Abandoned
- 2012-03-30 WO PCT/US2012/031338 patent/WO2012135560A1/en active Application Filing
- 2012-03-30 PL PL12716825T patent/PL2694971T3/pl unknown
- 2012-03-30 LT LTEP12716825.0T patent/LT2694971T/lt unknown
- 2012-03-30 CN CN201280016743.7A patent/CN103608681A/zh active Pending
- 2012-03-30 CA CA2831567A patent/CA2831567A1/en not_active Abandoned
- 2012-03-30 MX MX2013011428A patent/MX360225B/es active IP Right Grant
- 2012-03-30 BR BR112013025287A patent/BR112013025287A2/pt not_active IP Right Cessation
- 2012-03-30 RS RS20200616A patent/RS60678B1/sr unknown
- 2012-03-30 DK DK12716825.0T patent/DK2694971T3/da active
- 2012-03-30 HU HUE12716825A patent/HUE050711T2/hu unknown
- 2012-03-30 EP EP12716825.0A patent/EP2694971B1/en active Active
- 2012-03-30 ES ES12716825T patent/ES2793485T3/es active Active
- 2012-03-30 JP JP2014502816A patent/JP2014513283A/ja active Pending
- 2012-03-30 SI SI201231787T patent/SI2694971T1/sl unknown
- 2012-03-30 PT PT127168250T patent/PT2694971T/pt unknown
- 2012-03-30 KR KR1020137028837A patent/KR20140019823A/ko not_active Application Discontinuation
-
2013
- 2013-09-29 IL IL228564A patent/IL228564B/en active IP Right Grant
-
2017
- 2017-10-26 JP JP2017207034A patent/JP6707505B2/ja active Active
-
2020
- 2020-05-28 HR HRP20200860TT patent/HRP20200860T1/hr unknown
- 2020-05-29 CY CY20201100488T patent/CY1123191T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
HUE050711T2 (hu) | 2020-12-28 |
MX2013011428A (es) | 2014-06-23 |
WO2012135560A1 (en) | 2012-10-04 |
PT2694971T (pt) | 2020-06-16 |
HRP20200860T1 (hr) | 2020-09-04 |
SI2694971T1 (sl) | 2020-09-30 |
KR20140019823A (ko) | 2014-02-17 |
JP2018021934A (ja) | 2018-02-08 |
CY1123191T1 (el) | 2021-10-29 |
MX360225B (es) | 2018-10-25 |
JP6707505B2 (ja) | 2020-06-10 |
ES2793485T3 (es) | 2020-11-16 |
DK2694971T3 (da) | 2020-06-02 |
IL228564A0 (en) | 2013-12-31 |
EP2694971B1 (en) | 2020-03-04 |
RS60678B1 (sr) | 2020-09-30 |
JP2014513283A (ja) | 2014-05-29 |
IL228564B (en) | 2018-08-30 |
CN103608681A (zh) | 2014-02-26 |
US20120252038A1 (en) | 2012-10-04 |
BR112013025287A2 (pt) | 2017-11-14 |
EP2694971A1 (en) | 2014-02-12 |
LT2694971T (lt) | 2020-08-10 |
CA2831567A1 (en) | 2012-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL268157B (en) | A t-cell receptor with specificity for mage-a12 in the hla-cw7 environment | |
ZA201306950B (en) | ASSAYS FOR DETECTING AUTOANTIBODIES TO ANFI-TNFa DRUGS | |
EP2707719A4 (en) | DEVICE FOR DETECTING TUMOR CELLS | |
AP2013007142A0 (en) | T cell receptor-like antibodies specific for a WT1peptide presented by HLA-A2 | |
EP2720039A4 (en) | MEDIUM TO IMPROVE A CANCER HARVEST | |
EP2748335A4 (en) | URINBIOMARKER | |
IL222533A0 (en) | Methods for detecting antibodies | |
ZA201404463B (en) | Detecting analytes | |
HUP1100008A2 (en) | Serum for soil | |
EP2657346A4 (en) | METHOD FOR THE DETECTION OF CANCER CELLS | |
HK1197432A1 (zh) | 用於電化學測試條的試劑 | |
GB201118293D0 (en) | Electrochemical assay | |
IL230585A (en) | Estrogen receptor ligands | |
EP2603799A4 (en) | SIDEFLOW ASSAYS FOR NON-DIAGNOSTIC ANALYSIS | |
EP2935663A4 (en) | MICROPOWER ARRANGEMENTS FOR MYELINIZATION TESTS | |
EP2718459A4 (en) | DETECTION ARRAYS ON COMPETITIVE BASIS | |
GB201105979D0 (en) | Novel estrogen receptor ligands | |
IL228564B (en) | Steroid receptor testers for detecting mast cells | |
HUE058968T2 (hu) | Sejtkultúra tenyésztésére szolgáló eszköz | |
EP2712423A4 (en) | ANALYZES FOR DETECTING ENZYMATIC ACTIVITY | |
EP2726868A4 (en) | CELL BINDING TEST | |
GB201105984D0 (en) | Novel estrogen receptor ligands | |
GB201105983D0 (en) | Novel estrogen receptor ligands | |
GB201116427D0 (en) | T cell receptors | |
GB201112068D0 (en) | Cell development system |